2-[2-[4-(3-fluoro-5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetic acid;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-2-methylpropanoic acid;5-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-4-oxopentanoic acid;methyl 2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetate

C101H96FN33O13 — CID 164971843

IUPAC2-[2-[4-(3-fluoro-5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetic acid;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-2-methylpropanoic acid;5-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-4-oxopentanoic acid;methyl 2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetate
SMILESCC(C)(C(=O)O)n1cnc2c(-n3ncc4ccccc43)nc(N3CCN(c4ccc(O)cc4)CC3)nc21.COC(=O)Cn1cnc2c(-n3ncc4ccccc43)nc(N3CCN(c4ccc(O)cc4)CC3)nc21.O=C(O)CCC(=O)Cn1cnc2c(-n3ncc4ccccc43)nc(N3CCN(c4ccc(O)cc4)CC3)nc21.O=C(O)Cn1cnc2c(-n3ncc4ccccc43)nc(N3CCN(c4ncc(O)cc4F)CC3)nc21
InChIInChI=1S/C27H26N8O4.C26H26N8O3.C25H24N8O3.C23H20FN9O3/c36-20-7-5-19(6-8-20)32-11-13-33(14-12-32)27-30-25-24(28-17-34(25)16-21(37)9-10-23(38)39)26(31-27)35-22-4-2-1-3-18(22)15-29-35;1-26(2,24(36)37)33-16-27-21-22(33)29-25(30-23(21)34-20-6-4-3-5-17(20)15-28-34)32-13-11-31(12-14-32)18-7-9-19(35)10-8-18;1-36-21(35)15-32-16-26-22-23(32)28-25(29-24(22)33-20-5-3-2-4-17(20)14-27-33)31-12-10-30(11-13-31)18-6-8-19(34)9-7-18;24-16-9-15(34)11-25-20(16)30-5-7-31(8-6-30)23-28-21-19(26-13-32(21)12-18(35)36)22(29-23)33-17-4-2-1-3-14(17)10-27-33/h1-8,15,17,36H,9-14,16H2,(H,38,39);3-10,15-16,35H,11-14H2,1-2H3,(H,36,37);2-9,14,16,34H,10-13,15H2,1H3;1-4,9-11,13,34H,5-8,12H2,(H,35,36)
InChIKeyDFQNSTKTKWJXJX-UHFFFAOYSA-N
MW1999.09 g/mol
LogP9.83
Rot. Bonds23

About 2-[2-[4-(3-fluoro-5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetic acid;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-2-methylpropanoic acid;5-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-4-oxopentanoic acid;methyl 2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetate

2-[2-[4-(3-fluoro-5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetic acid;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-2-methylpropanoic acid;5-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-4-oxopentanoic acid;methyl 2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetate (PubChem CID 164971843) has the molecular formula C101H96FN33O13 and a molecular weight of 1999.09 g/mol. Its IUPAC name is 2-[2-[4-(3-fluoro-5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetic acid;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-2-methylpropanoic acid;5-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-4-oxopentanoic acid;methyl 2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetate.

Molecular Properties

Compound Name2-[2-[4-(3-fluoro-5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetic acid;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-2-methylpropanoic acid;5-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-4-oxopentanoic acid;methyl 2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetate
PubChem CID164971843
Molecular FormulaC101H96FN33O13
Molecular Weight1999.09 g/mol
Exact Mass1997.78
IUPAC Name2-[2-[4-(3-fluoro-5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetic acid;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-2-methylpropanoic acid;5-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-4-oxopentanoic acid;methyl 2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetate
SMILESCC(C)(C(=O)O)n1cnc2c(-n3ncc4ccccc43)nc(N3CCN(c4ccc(O)cc4)CC3)nc21.COC(=O)Cn1cnc2c(-n3ncc4ccccc43)nc(N3CCN(c4ccc(O)cc4)CC3)nc21.O=C(O)CCC(=O)Cn1cnc2c(-n3ncc4ccccc43)nc(N3CCN(c4ccc(O)cc4)CC3)nc21.O=C(O)Cn1cnc2c(-n3ncc4ccccc43)nc(N3CCN(c4ncc(O)cc4F)CC3)nc21
InChIInChI=1S/C27H26N8O4.C26H26N8O3.C25H24N8O3.C23H20FN9O3/c36-20-7-5-19(6-8-20)32-11-13-33(14-12-32)27-30-25-24(28-17-34(25)16-21(37)9-10-23(38)39)26(31-27)35-22-4-2-1-3-18(22)15-29-35;1-26(2,24(36)37)33-16-27-21-22(33)29-25(30-23(21)34-20-6-4-3-5-17(20)15-28-34)32-13-11-31(12-14-32)18-7-9-19(35)10-8-18;1-36-21(35)15-32-16-26-22-23(32)28-25(29-24(22)33-20-5-3-2-4-17(20)14-27-33)31-12-10-30(11-13-31)18-6-8-19(34)9-7-18;24-16-9-15(34)11-25-20(16)30-5-7-31(8-6-30)23-28-21-19(26-13-32(21)12-18(35)36)22(29-23)33-17-4-2-1-3-14(17)10-27-33/h1-8,15,17,36H,9-14,16H2,(H,38,39);3-10,15-16,35H,11-14H2,1-2H3,(H,36,37);2-9,14,16,34H,10-13,15H2,1H3;1-4,9-11,13,34H,5-8,12H2,(H,35,36)
InChIKeyDFQNSTKTKWJXJX-UHFFFAOYSA-N
XLogP9.83
TPSA520.68 Ų
H-Bond Donors7
H-Bond Acceptors43
Rotatable Bonds23
Heavy Atoms148
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001999.09
LogP ≤ 59.83
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1043

Analyze 2-[2-[4-(3-fluoro-5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetic acid;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-2-methylpropanoic acid;5-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-4-oxopentanoic acid;methyl 2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[2-[4-(3-fluoro-5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetic acid;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-2-methylpropanoic acid;5-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-4-oxopentanoic acid;methyl 2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetate?
The IUPAC name of 2-[2-[4-(3-fluoro-5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetic acid;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-2-methylpropanoic acid;5-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-4-oxopentanoic acid;methyl 2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetate (CID 164971843) is 2-[2-[4-(3-fluoro-5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetic acid;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-2-methylpropanoic acid;5-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-4-oxopentanoic acid;methyl 2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetate.
What is the SMILES notation for 2-[2-[4-(3-fluoro-5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetic acid;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-2-methylpropanoic acid;5-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-4-oxopentanoic acid;methyl 2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetate?
The canonical SMILES for 2-[2-[4-(3-fluoro-5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetic acid;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-2-methylpropanoic acid;5-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-4-oxopentanoic acid;methyl 2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetate is CC(C)(C(=O)O)n1cnc2c(-n3ncc4ccccc43)nc(N3CCN(c4ccc(O)cc4)CC3)nc21.COC(=O)Cn1cnc2c(-n3ncc4ccccc43)nc(N3CCN(c4ccc(O)cc4)CC3)nc21.O=C(O)CCC(=O)Cn1cnc2c(-n3ncc4ccccc43)nc(N3CCN(c4ccc(O)cc4)CC3)nc21.O=C(O)Cn1cnc2c(-n3ncc4ccccc43)nc(N3CCN(c4ncc(O)cc4F)CC3)nc21.
What is the InChIKey of 2-[2-[4-(3-fluoro-5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetic acid;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-2-methylpropanoic acid;5-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-4-oxopentanoic acid;methyl 2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetate?
The InChIKey is DFQNSTKTKWJXJX-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H26N8O4.C26H26N8O3.C25H24N8O3.C23H20FN9O3/c36-20-7-5-19(6-8-20)32-11-13-33(14-12-32)27-30-25-24(28-17-34(25)16-21(37)9-10-23(38)39)26(31-27)35-22-4-2-1-3-18(22)15-29-35;1-26(2,24(36)37)33-16-27-21-22(33)29-25(30-23(21)34-20-6-4-3-5-17(20)15-28-34)32-13-11-31(12-14-32)18-7-9-19(35)10-8-18;1-36-21(35)15-32-16-26-22-23(32)28-25(29-24(22)33-20-5-3-2-4-17(20)14-27-33)31-12-10-30(11-13-31)18-6-8-19(34)9-7-18;24-16-9-15(34)11-25-20(16)30-5-7-31(8-6-30)23-28-21-19(26-13-32(21)12-18(35)36)22(29-23)33-17-4-2-1-3-14(17)10-27-33/h1-8,15,17,36H,9-14,16H2,(H,38,39);3-10,15-16,35H,11-14H2,1-2H3,(H,36,37);2-9,14,16,34H,10-13,15H2,1H3;1-4,9-11,13,34H,5-8,12H2,(H,35,36).
What are the key properties of 2-[2-[4-(3-fluoro-5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetic acid;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-2-methylpropanoic acid;5-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-4-oxopentanoic acid;methyl 2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetate?
2-[2-[4-(3-fluoro-5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetic acid;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-2-methylpropanoic acid;5-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-4-oxopentanoic acid;methyl 2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetate has a molecular weight of 1999.09 g/mol, XLogP of 9.83, 23 rotatable bonds, 7 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-[4-(3-fluoro-5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetic acid;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-2-methylpropanoic acid;5-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]-4-oxopentanoic acid;methyl 2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]acetate is sourced from PubChem (CID 164971843), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).